Users of this system, can login to view this document.


Enter the following information to request a copy of the document from the responsible person.

Phase III Study of PSC-833 (Valspodar) in Combination with Vincristine, Doxorubicin, and Dexamethasone (Valspodar/VAD) versus VAD Alone in Patients with Recurring or Refractory Multiple Myeloma (E1A95)

This email address is used for sending the document.